Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology

Journal of Molecular Diagnostics

Volumn 8, Issue 3, 2006, Pages 312-319

  Parr, Ryan L ^a   Dakubo, Gabriel D ^a   Crandall, Keith A ^d   Maki, Jennifer ^a   Reguly, Brian ^a   Aguirre, Andrea ^a   Wittock, Roy ^a   Robinson, Kerry ^a   Alexander, Jude S ^a   Birch Machin, Mark A ^c   Abdel Malak, Mamdouh ^b   Froberg, M Kent ^e   Diamandis, Eleftherios P ^f   Thayer, Robert E ^a  

^a Genesis Genomics Incoporated   (Canada)

^b THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE   (Canada)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d BRIGHAM YOUNG UNIVERSITY   (United States)

^e UNIVERSITY OF MINNESOTA DULUTH   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE TUMOR; PROSTATECTOMY;

EID: 33745984239     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2006.050112     Document Type: Article

References (39)

1. Singh KK: Mitochondria damage checkpoint in apoptosis and genome stability. FEMS Yeast Res 2004, 5:127-132
2. Modica-Napolitano JS, Singh K: Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med 2002, 2002:1-19
3. Brenner C, Kroemer G: Apoptosis. Mitochondria - the death signal integrators. Science 2000, 289:1150-1151
4. Kroemer G, Reed JC: Mitochondrial control of cell death. Nat Med 2000, 6:513-519
5. Van Houten B, Woshner V, Santos JH: Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amst) 2006, 5:145-152
6. Copeland WC, Wachsman JT, Johnson FM, Penta JS: Mitochondrial DNA alterations in cancer. Cancer Invest 2002, 20:557-569
7. Penta JS, Johnson FM, Wachsman JT, Copeland WC: Mitochondrial DNA in human malignancy. Mutat Res 2001, 488:119-133
8. Carew JS, Huang P: Mitochondrial defects in cancer. Mol Cancer 2002, 1:9
9. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D: Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000, 287:2017-2019
10. Jeronimo C, Nomoto S, Caballero OL, Usadel H, Henrique R, Varzim G, Oliveira J, Lopes C, Fliss MS, Sidransky D: Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 2001, 20:5195-5198
11. Zhu W, Qin W, Bradley P, Wessel A, Puckett CL, Sauter ER: Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis 2005, 26:145-152
12. Chen JZ, Gokden N, Greene GF, Green B, Kadlubar FF: Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis. Carcinogenesis 2003, 24:1481-1487
13. Chen JZ, Gokden N, Greene GF, Mukunyadzi P, Kadlubar FF: Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection. Cancer Res 2002, 62:6470-6474
14. Lim SD, Sun C, Lambeth JD, Marshall F, Amin M, Chung L, Petros JA, Arnold RS: Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 2005, 62:200-207
15. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, Marshall FF, Wallace DC: mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005, 102:719-724
16. Bandelt HJ, Lahermo P, Richards M, Macaulay V: Detecting errors in mtDNA data by phylogenetic analysis. Int J Legal Med 2001. 115:64-69
17. Salas A, Carracedo A, Macaulay V, Richards M, Bandelt HJ: A practical guide to mitochondrial DNA error prevention in clinical, forensic, and population genetics. Biochem Biophys Res Commun 2005, 335:891-899
18. Nickerson DA, Tobe VO, Taylor SL: PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997, 25:2745-2751
19. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N: Reanalysis and revision of the Cambridge reference sequence for human mitochondral DNA. Nat Genet 1999, 23:147
20. Lopez JV, Cevario S, O'Brien SJ: Complete nucleotide sequences of the domestic cat (Felis catus) mitochondrial genome and a transposed mtDNA tandem repeat (Numt) in the nuclear genome. Genomics 1996, 33:229-246
21. King MP, Attardi G: Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 1989, 246:500-503
22. Salas A, Yao YG, Macaulay V, Vega A, Carracedo A. Bandelt HJ: A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2005, 2:e296
23. Saitou N, Nei M: The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987, 4:406-425
24. Huelsenbeck JP, Ronquist F, Nielsen R, Bollback JP: Bayesian inference of phylogeny and its impact on evolutionary biology. Science 2001, 294:2310-2314
25. Posada D, Crandall KA: MODELTEST: testing the model of DNA substitution. Bioinformatics 1998, 14:817-818
26. Swofford DL: PAUP*: Phylogenetic Analysis Using Parsimony (*and Other Methods). Sinauer, Sunderland, 2002
27. Huelsenbeck JP, Ronquist F: MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 2001, 17:754-755
28. Hasegawa M, Cao Y, Yang Z: Preponderance of slightly deleterious polymorphism in mitochondrial DNA: nonsynonymous/synonymous rate ratio is much higher within species than between species. Mol Biol Evol 1998, 15:1499-1505
29. Mairinger T, Mikuz G, Gschwendtner A: Nuclear chromatin texture analysis of nonmalignant tissue can detect adjacent prostatic adenocarcinoma. Prostate 1999, 41:12-19
30. Montironi R, Diamanti L, Pomante R, Thompson D, Bartels PH: Subtle changes in benign tissue adjacent to prostate neoplasia detected with a Bayesian belief network. J Pathol 1997, 182:442-449
31. Chandran UR, Dhir R, Ma C, Michalopoulos G, Becich MJ, Gilbertson JR: Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer 2005, 5:45
32. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, McDonald C, Thomas R, Dhir R, Finkelstein S, Michalopoulos G, Becich M, Luo JH: Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 2004, 22:2790-2799
33. Augenlicht LH, Heerdt BG: Modulation of gene expression as a biomarker in colon. J Cell Biochem Suppl 1992, 16G:S151-S157
34. Amuthan G, Biswas G, Zhang SY, Klein-Szanto A, Vijayasarathy C, Avadhani NG: Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J 2001, 20:1910-1920
35. Schoeler S, Szibor R, Gellerich FN, Wartmann T, Mawrin C, Dietzmann K, Kirches E: Mitochondrial DNA deletions sensitize cells to apoptosis at low heteroplasmy levels. Biochem Biophys Res Commun 2005, 332:43-49
36. Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V, Wallace DC: Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 2004, 303:223-226
37. Payseur BA, Nachman MW: Natural selection at linked sites in humans. Gene 2002, 300:31-42
38. Jakupciak JP, Wang W, Markowitz ME, Ally D, Coble M, Srivastava S, Maitra A, Barker PE, Sidransky D, O'Connell CD: Mitochondrial DNA as a cancer biomarker. J Mol Diagn 2005, 7:258-267
39. Maitra A, Cohen Y, Gillespie SE, Mambo E, Fukushima N, Hoque MO, Shah N, Goggins M, Califano J, Sidransky D, Chakravarti A: The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res 2004, 14:812-819